In the complex world of autoimmune disease, Dr. Lisa Christopher-Stine stands as a leader in innovation, compassion, and scientific discovery. As a Professor of Medicine and Neurology at The Johns Hopkins University School of Medicine and the  Director of the Johns Hopkins Myositis Center, she is a world-renowned leader whose work has fundamentally reshaped the understanding and treatment of inflammatory muscle diseases.

A true clinician-scientist, Dr. Christopher-Stine’s research has been transformative. Her most significant contribution was the co-discovery of the anti-HMGCR autoantibody, which defined a new subtype of statin-associated immune-mediated necrotizing myopathy. This groundbreaking work, created a new diagnostic paradigm, enabling clinicians worldwide to identify and treat patients who were previously misdiagnosed. Her prolific research is anchored by her role as the principal investigator for the Johns Hopkins Myositis Research Registry—a global cohort of over 3,000 patients that serves as a vital resource for myositis studies.

Beyond her research, Dr. Christopher-Stine is a dedicated educator and a passionate advocate for patient-centered care. She co-chairs an international OMERACT initiative to develop patient-reported outcome measures, ensuring the patient perspective is integral to clinical trials. Patients describe her as a deeply compassionate physician who “cares about the whole me, not just my myositis.”